ClinicalMetric / Countries / Netherlands / sepsis
← 🇳🇱 Netherlands Trials
🇳🇱 Netherlands Country × Condition

sepsis Clinical Trials in Netherlands

Active clinical trials for sepsis with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands

Active Trials in Netherlands (3)

NCT06624436 Phase 4
Recruiting

Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia

Enrollment
52 pts
Country
🇳🇱 Netherlands
Radboud University Medical Center
View Trial →
NCT04615065
Recruiting

Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine

Enrollment
35,000 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial →
NCT06624618
Recruiting

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit

Enrollment
300 pts
Country
🇳🇱 Netherlands
Maastricht University Medical Cente...
View Trial →

Frequently Asked Questions

How many sepsis clinical trials are active in Netherlands?
There are currently 3 active clinical trials for sepsis with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a sepsis clinical trial in Netherlands?
To join a sepsis clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are sepsis trials in Netherlands?
Active sepsis trials in Netherlands span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Netherlands Trials → Global sepsis Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology